We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Stiefel announced in a press release ...

LAVAL, QC / ACCESSWIRE / January 30, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its dermatology business, Ortho Dermatologics, today announced the U.S. launch of CABTREO™ (clindamycin ...

July 3, 2002 -- The combination of topical clindamycin with benzoyl peroxide is more effective than clindamycin alone at reducing Propionibacterium acnes bacterial counts, according to results of a ...

July 20, 2007 (Chicago) -- A gel that combines topical 1.2% clindamycin and 0.025% tretinoin treats acne vulgaris in children aged 12 to 18 years as or more effectively than either of its active ...

LAVAL, QC / ACCESS Newswire / July 9, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that PrCABTREOTM (clindamycin phosphate, adapalene ...

LAVAL, QC / ACCESSWIRE / November 18, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE/TSX:BHC), today announced that Pr CABTREO TM (clindamycin phosphate, adapalene and ...

CABTREO is the first and only triple-combination topical treatment for acne approved by Health Canada with three mechanisms of action - an antibiotic, a retinoid and an antibacterial agent - to ...

FT. WORTH, Texas--(BUSINESS WIRE)--One of the most widely prescribed drugs for acne vulgaris is benzoyl peroxide (BPO). However, at concentrations of 5-10%, BPO has the potential for skin irritation ...

Perrigo announced a recall of 10 lots of Clindamycin Phosphate and Benzoyl Peroxide Gel (1.2%/5%) due to the presence of a small amount of mold on the caps of the ...